Nitrofurantoina Doc

Nitrofurantoin, the active ingredient in Nitrofurantoina Doc, is a nitrofuran antibiotic presented as an oral formulation for oral use. It exerts bactericidal activity against common urinary pathogens such as Escherichia coli and Enterococcus species, and is indicated for the treatment of uncomplicated urinary tract infections, including cystitis, in adult patients.

GNH USA supplies Nitrofurantoina Doc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across EU and global markets through robust quality‑assurance processes.

Nitrofurantoina Doc is a nitrofuran antibiotic used to treat infections of the urinary tract.

Uncomplicated urinary tract infection: eliminates the causative bacteria and resolves symptoms. Cystitis: clears bladder infection and prevents recurrence. Recurrent urinary tract infection prophylaxis: provides short‑term preventive therapy to reduce recurrence risk.

Nitrofurantoina Doc may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild stomach upset occurring after dosing. - Vomiting: occasional expulsion of stomach contents. - Diarrhea: loose stools that may be transient. - Headache: mild to moderate cranial pain. - Loss of appetite: reduced desire to eat. - Metallic taste: transient alteration of taste perception.

Serious or Rare Side Effects: - Pulmonary toxicity: interstitial lung disease or acute respiratory distress. - Liver injury: hepatitis or elevated liver enzymes. - Severe allergic reactions: rash, Stevens‑Johnson syndrome, or anaphylaxis. - Hemolytic anemia in G6PD deficiency: rapid destruction of red blood cells. - Peripheral neuropathy: tingling or numbness in extremities. - Blood dyscrasias: agranulocytosis, leukopenia, or thrombocytopenia.

When prescribing Nitrofurantoina Doc, clinicians should consider several safety aspects to minimise risk.

Renal function: assess kidney function and avoid use if creatinine clearance is below 60 mL/min. Pregnancy: avoid use unless benefits outweigh risks, especially during the first trimester. G6PD deficiency: contraindicated due to risk of hemolysis. History of lung disease: monitor for pulmonary reactions. Concurrent antacids: separate dosing as antacids may reduce absorption. Store at below 25°C: keep in the original pack, protect from moisture.

Nitrofurantoina Doc can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: decrease nitrofurantoin absorption. - Probenecid: reduces renal excretion, increasing systemic exposure. - Warfarin: may potentiate anticoagulant effect and raise INR. - Oral contraceptives: may reduce hormonal effectiveness.

Moderate Interactions (Monitor Closely): - Diuretics: may increase nitrofurantoin concentration, raising renal risk. - NSAIDs: combined use can stress renal function. - High‑dose vitamin C: may enhance absorption and side‑effect potential.